References
- Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18–22 April 2004. Am J Hematol 2005; 79: 319–28
- Palladini G, Perfetti V, Merlini G. Therapy and management of systemic AL (primary) amyloidosis. Swiss Med Wkly 2006; 136: 715–20
- Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003; 349: 583–96
- Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997; 337: 898–909
- Pezzini A, Padovani A. Cerebral amyloid angiopathy-related hemorrhages. Neurol Sci 2008; 29 Suppl 2: S260–3
- Mulleman D, Flipo RM, Assaker R, Maurage CA, Chastanet P, Ducoulombier V, et al. Primary amyloidoma of the axis and acute spinal cord compression: a case report. Eur Spine J 2004; 13: 244–8
- Pasternak S, Wright BA, Walsh N. Soft tissue amyloidoma of the extremities: report of a case and review of the literature. Am J Dermatopathol 2007; 29: 152–5
- Gilat T, Spiro HM. Amyloidosis and the gut. Am J Dig Dis 1968; 13: 619–33
- Ebert EC, Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol 2008; 103: 776–87
- Petre S, Shah IA, Gilani N. Gastrointestinal amyloidosis: clinical features, diagnosis and therapy [review article]. Aliment Pharmacol Ther 2008; 27: 1006–16
- Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45–59
- Caccialanza R, Palladini G, Klersy C, Cena H, Vagia C, Cameletti B, et al. Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis 1. Am J Clin Nutr 2006; 83: 350–4
- Sanchorawala V. Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol 2006; 1: 1331–41
- Schaadt BK, Hendel HW, Gimsing P, Jonsson V, Pedersen H, Hesse B. 99mTc-aprotinin scintigraphy in amyloidosis. J Nucl Med 2003; 44: 177–83
- Ghio S, Perlini S, Palladini G, Marsan NA, Faggiano G, Vezzoli M, et al. Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis. Eur J Heart Fail 2007; 9: 808–13
- Bergesio F, Ciciani AM, Santostefano M, Brugnano R, Manganaro M, Palladini G, et al. Renal involvement in systemic amyloidosis: an Italian retrospective study on epidemiological and clinical data at diagnosis. Nephrol Dial Transplant 2007; 22: 1608–18
- Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004; 140: 85–93
- Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Kumar S. Transplantation for amyloidosis. Curr Opin Oncol 2007; 19: 136–41
- Hayman SR, Lacy MQ, Kyle RA, Gertz MA. Primary systemic amyloidosis: a cause of malabsorption syndrome. Am J Med 2001; 111: 535–40